Category:BTK inhibitors

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 18:57, 14 November 2014 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

A class of drugs that inhibit Bruton's tyrosine kinase (BTK). The first drug approved in this class is Ibrutinib (Imbruvica).

Pages in category "BTK inhibitors"

The following 8 pages are in this category, out of 8 total.

A

Acalabrutinib (Calquence)

D

Dasatinib (Sprycel)

I

Ibrutinib (Imbruvica)

P

Pirtobrutinib (Jaypirca)

R

Rilzabrutinib (PRN-1008)

S

Spebrutinib (CC-292)

T

Tirabrutinib (Velexbru)

Z

Zanubrutinib (Brukinsa)

Retrieved from "https://hemonc.org/w/index.php?title=Category:BTK_inhibitors&oldid=5703"

Kinase inhibitors